Skip to main content

Table 6 Wilcoxon sign-rank test was used to test the difference between pre-PP1M and Post-PP1M. Comparison of Indirect Costs Before and After Transition to PP1M

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

  Caregiver care costs Productivity costs Indirect costs
pre-PP1M (¥) 3830±3260 11,767±8133 15,967±10,128
Post-PP1M (¥) 2141±4044 8137±8150 10,279±11,878
Difference -44.10% -30.85% -35.62%
P ≤ 0.01 ≤ 0.01 < 0.01